^*Only publications of international collaborations are included in this list starting with the most recent publication; for (inter)national publications of the national teams see the respective pages.

• Andrade LEC, Damoiseaux J, Vergani D, Fritzler MJ.
  Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases.
  J Transl Autoimmun. 2022;5:100145. doi: 10.1016/j.jtauto.2022.100145.
  
  
• Bonroy C, Piette Y, Allenbach Y, Bossuyt X, Damoiseaux J.
  Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-up.
  J Transl Autoimmun. 2022;5:100148. doi: 10.1016/j.jtauto.2022.100148.
  
  
• Damoiseaux J.
  Autoantibodies in the criteria of autoimmune diseases: is it sufficient to know that the test is positive?
  J Transl Autoimmun. 2022;5:100144. doi: 10.1016/j.jtauto.2022.100144.
  
  
• Damoiseaux J, Mammen AL, Piette Y, Benveniste O, Allenbach Y;
  ENMC 256th Workshop Study Group.
  256th ENMC international workshop: Myositis specific and associated autoantibodies (MSA-ab): Amsterdam, The Netherlands, 8-10 October 2021. Neuromuscul Disord. 2022;32(7):594-608. doi: 10.1016/j.nmd.2022.05.011.
  
  
• Damoiseaux J, Potjewijd J, Smeets RL, Bonroy C.
  Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application.
  J Transl Autoimmun. 2022;5:100141. doi: 10.1016/j.jtauto.2022.100141.
  
  
• Dragon-Durey MA, Bizzaro N, Senant M, Andreeva H, Bogdanos DP, Bonroy C, Bossuyt X, Eriksson C, Fabien N, Heijnen I, Herold M, Musset L, Kuhi L, Lopez-Hoyos M, Berki T, Roozendaal C, Sack U, Sundic T, Taylor L, Kuna AT, Damoiseaux J.
  Repository of intra- and inter-run variations of quantitative autoantibody assays: a European multicenter study.
  Clin Chem Lab Med. 2022;60(9):1373-1383. doi: 10.1515/cclm-2022-0411.
  
  
• van Beers JJBC, Schreurs MWJ.
  Anti-Sm antibodies in the classification criteria of systemic lupus erythematosus.
  J Transl Autoimmun. 2022;5:100155. doi: 10.1016/j.jtauto.2022.100155.
  
  
• Infantino M, Nagy E, Bizzaro N, Fischer K, Bossuyt X, Damoiseaux J.
  Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus.
  J Transl Autoimmun. 2021;5:100139. doi: 10.1016/j.jtauto.2021.100139.
  
  
• Nagy E, Infantino M, Bizzaro N, Andreeva H, Bontkes HJ, Bossuyt X, Fabien N, Fischer K, Heijnen IAFM, Herold M, Kozmar A, Kuhi L, López-Hoyos M, Pullerits R, Sousa MJR, Tsirogianni A, Damoiseaux J; European Autoimmunity Standardisation Initiative. The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned.
  Autoimmun Rev. 2021;20(12):102985. doi: 10.1016/j.autrev.2021.102985.
  
  
• Veenbergen S, Kozmar A, van Daele PLA, Schreurs MWJ. Autoantibodies in Sjögren's syndrome and its classification criteria.
  J Transl Autoimmun. 2021;5:100138. doi: 10.1016/j.jtauto.2021.100138.
  
  
• Bossuyt X, Damoiseaux J, Rasmussen N, van Paassen P, Hellmich B, Baslund B, Blockmans D, Vermeersch P, Lopez-Hoyos M, Vercammen M, Barret E, Hammar F, Leinfelder U, Mahler M, Olschowka N, Roggenbuck D, Schlumberger W, Walker R, Rönnelid J, Cohen Tervaert JW, Csernok E, Fierz W; for (i) the European Federation of Laboratory Medicine (EFLM) Task and Finish Group “Autoimmunity Testing,” (ii) the European Autoimmune Standardization Initiative (EASI) and the (iii) European Consensus Finding Study Group on autoantibodies (ECFSG). Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper.
  Clin Chem Lab Med. 2020;59(2):e35-e39. doi: 10.1515/cclm-2020-1178.
  
  
• Damoiseaux J. The perspective on standardisation and harmonisation: the viewpoint of the EASI president. Auto Immun Highlights. 2020;11(1):4. doi: 10.1186/s13317-020-0127-3.
  
  
• Sack U, Bossuyt X, Andreeva H, Antal-Szalmás P, Bizzaro N, Bogdanos D, Borzova E, Conrad K, Dragon-Durey MA, Eriksson C, Fischer K, Haapala AM, Heijnen I, Herold M, Klotz W, Kozmar A, Tesija Kuna A, López Hoyos M, Malkov VA, Musset L, Nagy E, Rönnelid J, Shoenfeld Y, Sundic T, Tsirogianni A, Uibo R, Rego Sousa MJ, Damoiseaux J; European Autoimmunity Standardisation Initiative. Quality and best practice in medical laboratories: specific requests for autoimmunity testing.
  Auto Immun Highlights. 2020;11(1):12. doi: 10.1186/s13317-020-00134-0.
  
  
• Van Hoovels L, Broeders S, Chan EKL, Andrade L, de Melo Cruvinel W, Damoiseaux J, Viander M, Herold M, Coucke W, Heijnen I, Bogdanos D, Calvo-Alén J, Eriksson C, Kozmar A, Kuhi L, Bonroy C, Lauwerys B, Schouwers S, Lutteri L, Vercammen M, Mayer M, Patel D, Egner W, Puolakka K, Tesija-Kuna A, Shoenfeld Y, de Sousa MJR, Hoyos ML, Radice A, Bossuyt X. Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns: results of an international survey.
  Auto Immun Highlights. 2020;11(1):17. doi: 10.1186/s13317-020-00139-9.
  
  
• Damoiseaux J, Vulsteke JB, Tseng CW, Platteel ACM, Piette Y, Shovman O, Bonroy C, Hamann D, De Langhe E, Musset L, Chen YH, Shoenfeld Y, Allenbach Y, Bossuyt X. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.
  Autoimmun Rev. 2019;18(3):293-305. doi: 10.1016/j.autrev.2018.10.004.
  
  
• Damoiseaux J, Heijnen I, Van Campenhout C, Eriksson C, Fabien N, Herold M, van der Molen RG, Egner W, Patel D, Plaza-Lopez A, Radice A, de Sousa MJR, Viander M, Shoenfeld Y. An international survey on anti-neutrophil cytoplasmic antibodies (ANCA) testing in daily clinical practice.
  Clin Chem Lab Med. 2018;56(10):1759-1770. doi: 10.1515/cclm-2017-0306.
  
  
• Damoiseaux J, Olschowka N, Shoenfeld Y. EASI - European Autoimmunity Standardisation Initiative: facing the challenges of diagnostics in autoimmunity.
  Clin Chem Lab Med. 2018 Sep 25;56(10):1620-1623. doi: 10.1515/cclm-2017-0826.
  
  
• Bizzaro N, Bossuyt X, Haapala AM, Shoenfeld Y, Sack U. Accreditation in autoimmune diagnostic laboratories. A position paper of the European Autoimmunity Standardisation Initiative (EASI).
  Autoimmun Rev. 2017;16(1):81-86. doi: 10.1016/j.autrev.2016.09.021.
  
  
• Damoiseaux J, Agmon-Levin N, Van Blerk M, Chopyak V, Eriksson C, Heijnen I, Herold M, Høgåsen K, Musset L, Radice A, Rego de Sousa MJ, Viander M, Shoenfeld Y. From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries.
  Clin Exp Rheumatol. 2014;32(4):539-46.
  
  
• Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M, Bossuyt X, Musset L, Cervera R, Plaza-Lopez A, Dias C, Sousa MJ, Radice A, Eriksson C, Hultgren O, Viander M, Khamashta M, Regenass S, Andrade LE, Wiik A, Tincani A, Rönnelid J, Bloch DB, Fritzler MJ, Chan EK, Garcia-De La Torre I, Konstantinov KN, Lahita R, Wilson M, Vainio O, Fabien N, Sinico RA, Meroni P, Shoenfeld Y. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.
  Ann Rheum Dis. 2014;73(1):17-23. doi: 10.1136/annrheumdis-2013-203863.
  
  
• Shoenfeld Y, Cervera R, Haass M, Kallenberg C, Khamashta M, Meroni P, Piette JC, Schmidt R, Wiik A. EASI - The European Autoimmunity Standardisation Initiative - A new initiative that can contribute to agreed diagnostic models of diagnosing autoimmune disorders throughout Europe.
  Ann NY Acad Sci 2007; 1109:138-144.
  
  
• Wiik A, Cervera R, Haass M, Kallenberg C, Khamashta M, Meroni PL, Piettel JC, Schmitt R, Shoenfeld Y. European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders.
  Lupus 2006; 15 (7):391-396.